Cargando…

Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer

BACKGROUND: Breast cancer is the most common malignancy in women, and neoadjuvant chemotherapy has been recommended to the patients with locally advanced breast cancer as the initial treatments. Long non-coding RNA (lncRNA) MEG3, an identified tumor suppressor, has been implicated in the development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bayarmaa, Battseren, Wu, Ziping, Peng, Jing, Wang, Yan, Xu, Shuguang, Yan, Tingting, Yin, Wenjin, Lu, Jinsong, Zhou, Liheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727505/ https://www.ncbi.nlm.nih.gov/pubmed/31488093 http://dx.doi.org/10.1186/s12885-019-6077-3

Ejemplares similares

LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer
por: Xu, Yaqian, et al.
Publicado: (2021)

Genetic polymorphisms of GGT1 gene (rs8135987, rs5751901 and rs2017869) are associated with neoadjuvant chemotherapy efficacy and toxicities in breast cancer patients
por: Sun, Lu, et al.
Publicado: (2023)

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
por: Du, Yueyao, et al.
Publicado: (2018)

Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
por: Wu, Ziping, et al.
Publicado: (2019)

Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study
por: Zhou, Liheng, et al.
Publicado: (2017)

Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant setting
por: Wu, Ziping, et al.
Publicado: (2019)

Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy
por: Sha, Rui, et al.
Publicado: (2021)

The Predictive Value of Pre-therapeutic Serum Gamma-glutamyl transferase in Efficacy and Adverse Reactions to Neoadjuvant Chemotherapy among Breast Cancer Patients
por: Sun, Lu, et al.
Publicado: (2020)

Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting
por: Wu, Ziping, et al.
Publicado: (2018)

Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy
por: Xu, Yaqian, et al.
Publicado: (2020)

Associations between lncRNA MEG3 polymorphisms and neuroblastoma risk in Chinese children
por: Zhuo, Zhen-Jian, et al.
Publicado: (2018)

Association of Neo-Family History Score with pathological complete response, safety, and survival outcomes in patients with breast cancer receiving neoadjuvant platinum-based chemotherapy: An exploratory analysis of two prospective trials
por: Xu, Yaqian, et al.
Publicado: (2021)

Multiparametric Contrast-Enhanced Ultrasound in Early Prediction of Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival in Breast Cancer
por: Wan, Caifeng, et al.
Publicado: (2023)

LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication
por: Sheng, Xiaonan, et al.
Publicado: (2021)

Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients
por: Dai, Huijuan, et al.
Publicado: (2021)

Upregulation of microRNA-1 inhibits proliferation and metastasis of breast cancer
por: Peng, Jing, et al.
Publicado: (2020)

Expression of lncRNA MEG3 in asthma with different phenotypes and its relationship with course of disease
por: Feng, Yan, et al.
Publicado: (2020)

Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target Therapy
por: Zhang, Shan, et al.
Publicado: (2020)

Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells
por: Li, Hongchang, et al.
Publicado: (2020)

The Association of MEG3 lncRNA with Nuclear Speckles in Living Cells
por: Hasenson, Sarah E., et al.
Publicado: (2022)

A review on the role of MEG8 lncRNA in human disorders
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

LncRNA POU3F3 promotes melanoma cell proliferation by downregulating lncRNA MEG3
por: Liu, Yingnan, et al.
Publicado: (2021)

lncRNA MEG8 is downregulated in osteoarthritis and regulates chondrocyte cell proliferation, apoptosis and inflammation
por: Xie, Wei, et al.
Publicado: (2021)

LncRNA HLA-F-AS1 Enhances the Migration, Invasion and Apoptosis of Glioblastoma Cells by Targeting lncRNA MEG3
por: Wang, Yanhua, et al.
Publicado: (2021)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
por: Zeng, Ying, et al.
Publicado: (2019)

LncRNA MEG3-TRPV1 signaling regulates chronic inflammatory pain in rats
por: Peng, Jing-Wei, et al.
Publicado: (2022)

Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3
por: Li, Xinyi, et al.
Publicado: (2018)

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
por: Li, Zining, et al.
Publicado: (2022)

First Efficacy Results of Capecitabine with Anthracycline- and Taxane-Based Adjuvant Therapy in High-Risk Early Breast Cancer: A Meta-Analysis
por: Jiang, Yiwei, et al.
Publicado: (2012)

LncRNA BCAR4 expression predicts the clinical response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
por: Gan, Feng-Jiao, et al.
Publicado: (2021)

Postoperative Fever: The Potential Relationship with Prognosis in Node Negative Breast Cancer Patients
por: Yan, Tingting, et al.
Publicado: (2010)

Association between lncRNA GAS5, MEG3, and PCAT-1 Polymorphisms and Cancer Risk: A Meta-Analysis
por: Dong, Xiaoyan, et al.
Publicado: (2020)

Down regulated lncRNA MEG3 eliminates mycobacteria in macrophages via autophagy
por: Pawar, Kamlesh, et al.
Publicado: (2016)

LncRNA Meg3 protects endothelial function by regulating the DNA damage response
por: Shihabudeen Haider Ali, Mohamed Sham, et al.
Publicado: (2019)

Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer
por: Buttarelli, Marianna, et al.
Publicado: (2020)

Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway
por: Uroda, Tina, et al.
Publicado: (2019)

Mechanism associated with aberrant lncRNA MEG3 expression in gestational diabetes mellitus
por: Zhang, Hailing
Publicado: (2019)

The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3
por: Chen, Jingjing, et al.
Publicado: (2019)

Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer
por: Wang, Yaohui, et al.
Publicado: (2018)

Retracted: Association between lncRNA GAS5, MEG3, and PCAT-1 Polymorphisms and Cancer Risk: A Meta-Analysis
por: Markers, Disease
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_50i9kr0ibj14n3l8dlpvaph1v5